You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
Dow
Johnson and Johnson
Medtronic

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

DEXTROAMPHETAMINE SULFATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Dextroamphetamine Sulfate patents expire, and what generic alternatives are available?

Dextroamphetamine Sulfate is a drug marketed by Able, Actavis Elizabeth, Mayne Pharma, Mylan, Nesher Pharms, PII, Specgx Llc, Vintage Pharms, Outlook Pharms, Tris Pharma Inc, Ani Pharms Inc, Arbor Pharms Llc, Aurolife Pharma Llc, Avanthi Inc, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Nuvo Pharm, Purepac Pharm, Sandoz, Vintage Pharms Llc, and Vitarine. and is included in thirty-one NDAs.

The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Dextroamphetamine Sulfate

A generic version of DEXTROAMPHETAMINE SULFATE was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.

  Start Trial

Drug patent expirations by year for DEXTROAMPHETAMINE SULFATE
Drug Prices for DEXTROAMPHETAMINE SULFATE

See drug prices for DEXTROAMPHETAMINE SULFATE

Recent Clinical Trials for DEXTROAMPHETAMINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Vallon Pharmaceuticals, Inc.Phase 1
Medical University of ViennaN/A
Centre hospitalier de l'Université de Montréal (CHUM)Phase 2

See all DEXTROAMPHETAMINE SULFATE clinical trials

Pharmacology for DEXTROAMPHETAMINE SULFATE
Medical Subject Heading (MeSH) Categories for DEXTROAMPHETAMINE SULFATE
Synonyms for DEXTROAMPHETAMINE SULFATE
(+)-?-Methylphenethylamine hemisulfate salt
(+)-alpha-Methylphenethylamine sulfate (2:1)
(+)-Amphetamine sulphate
(2S)-1-phenylpropan-2-amine;sulfuric acid
(S)-(+)-Amphetamine Sulphate (Dextroamphetamine Sulphate)
(S)-alpha-Methylbenzeneethanamine sulfate
(S)-amphetamine hemisulfate
(S)-amphetamine hemisulphate
(S)-Amphetamine sulfate
51-63-8
Acedron
Adderall
Adjudets
Adrizine
Afatin
AKOS024457301
Albemap
Algo-dex
alpha-Methylphenethylamine sulfate, d-form
Amdex
Amphaetex
Ampherex
AMPHETAMINE SULFATE, DEXTRO
Amphetasul
Amphex
Amptrerex
Apetain
API0002279
Ardex
Benzeneethanamine, alpha-methyl-, (alphaS)-, sulfate (2:1)
Benzeneethanamine, alpha-methyl-, (S)-, sulfate (2:1)
Betafedrina
Betafedrine
Betaphedrine
C9H13N.H2O4S
Carrtime
CHEMBL3544971
Cradex
Curban
D-1-Phenyl-2-aminopropane sulfate
d-alpha-Methylphenethylamine sulfate
D-Amfetasul
D-Amphetamine hemisulfate salt solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis
d-Amphetamine sulphate
D-Ate phenyl 747
d-beta-Phenylisopropylamine sulfate
D02078
Dadex
Dams
DAS (VAN)
Dasdel
Dellipsoids
Dex ob
Dex-Sule
Dexaline
Dexalme
Dexalone
Dexamed
Dexamfetamine sulfate
Dexamine
Dexampex
Dexedrina
Dexedrine (TN)
Dexedrine Sulfate
Dexies
Dexten
Dextenal
Dextro Amphetamine Sulfate Syrup
Dextro-alpha-methylphenethylamine sulfate
Dextro-Amphetamine Sulfate
Dextro-beta-phenylisopropylamine sulfate
Dextroamphetamine sulfate (USP)
Dextroamphetamine sulfate [USAN]
Dextroamphetamine sulfate [USP]
Dextroamphetamine Sulfate CII
Dextroamphetamine sulfate, United States Pharmacopeia (USP) Reference Standard, monograph mol wt. 368.49 ((C9H13N)2 ?? H2SO4)
Dextroamphetamine sulphate
Dextroanfetamina
Dextrostat (TN)
Dextrosule
Diocurb
Diphylets
Ditab
Domafate
Dura Dex
Dynaphenyl
EINECS 200-111-6
Ephadren
Evrodex
Fastballs
Ferndex
Hetamine
JJ768O327N
Lentanet
Lipsoids
Lowedex
LS-103686
Maxiton sulfate
Medex
Medex (VAN)
NSC 27104
Obesedrin
Obesonil
Oranges
Pellcap
Perke
Phenethylamine, alpha-methyl-, sulfate (2:1), (+)-
Phenethylamine,alpha-methyl-, sulfate, (+)
Phetadex
Pomadex
Pro-Dexter
Psychodrine
PYHRZPFZZDCOPH-QXGOIDDHSA-N
Q27122300
Recordati
Revidex
Robese
S-(+)-Amphetamine sulfate
SCHEMBL18948
Simpamina-D
Spancap
Sympamina-D
Tempodex
Tidex
Tuphetamine
Tydex
UNII-6DPV8NK46S component PYHRZPFZZDCOPH-QXGOIDDHSA-N
UNII-JJ768O327N
Zamine

US Patents and Regulatory Information for DEXTROAMPHETAMINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Llc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 090652-001 Mar 7, 2014 DISCN No No   Start Trial   Start Trial   Start Trial
Arbor Pharms Llc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 090533-005 Oct 25, 2011 RX No No   Start Trial   Start Trial   Start Trial
Nesher Pharms DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 206588-001 Mar 28, 2016 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
Dow
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.